Peter Grootenhuis

This inventor holds 35 USPTO granted patents and 24 published patent applications, plus 3 CIPO patents and 11 EPO patents, primarily in Cystic Fibrosis Modulators. Top assignees: Vertex Pharmaceuticals, Inc., Bristol-Myers Squibb Pharma Company, Syngenta Crop Protection, Inc.. Active years: 2003-2026.

USPTO Granted Patents = 35 (Patent Applications = 24)

% Patents Active = 94.3

CIPO Patents = 3 (Patent Applications = 1)

EPO Patents = 11 (Patent Applications = 23)

Average Co-Inventor Count = 7.4

ph-index = 19

Forward Citations = 1,491(Granted Patents)

Location History:

San Diego, CA (US) (2003 - 2020)
Del Mar, CA (US) (2020 - 2024)

Company Filing History:

32 out of 1,167

Vertex Pharmaceuticals, Inc.

patents

1 out of 234

Bristol-Myers Squibb Pharma Company

patents

1 out of 416

Syngenta Crop Protection, Inc.

patents

4. 1 out of 834,307

Other

patents

Years Active: 2003-2026

Loading Chart...

Areas of Expertise:

Cystic Fibrosis

CFTR Modulators

Pharmaceutical Compositions

ATP-Binding Cassette Transporters

Crystalline Forms

Pyridyl Derivatives

Synthetic Polysaccharides

Ion Channel Modulators

Methods of Treatment

Organic Compounds

Substituted Thiazoles

Oxazoles

35 patents (USPTO):Sort by Forward CitationsExplore Patents

1. 12612416 - Modulators of cystic fibrosis transmembrane conductance regulator (2026-04-28),

2. 12421251 - Cystic fibrosis transmembrane conductance regulator modulating agents (2025-09-23),

3. 12324802 - Modulators of cystic fibrosis transmembrane conductance regulator (2025-06-10),

4. 12319693 - Crystalline forms of CFTR modulators (2025-06-03),

5. 12122788 - Process of making CFTR modulators (2024-10-22),

6. 11873300 - Crystalline forms of CFTR modulators (2024-01-16),

7. 11866450 - Modulators of Cystic Fibrosis Transmembrane Conductance regulator, pharmaceutical compositions, methods of treatment, and process for making the modulators (2024-01-09),

8. 11591350 - Modulators of cystic fibrosis transmembrane conductance regulator (2023-02-28),

9. 11584761 - Process of making CFTR modulators (2023-02-21),

10. 11186566 - Modulator of cystic fibrosis transmembrane conductance regulator, pharmaceutical compositions, methods of treatment, and process for making the modulator (2021-11-30),

11. 11066417 - Modulators of cystic fibrosis transmembrane conductance regulator, pharmaceutical compositions, methods of treatment, and process for making the modulators (2021-07-20),

12. 10662192 - Modulators of ATP-binding cassette transporters (2020-05-26),

13. 10570115 - Modulator of cystic fibrosis transmembrane conductance regulator, pharmaceutical compositions, methods of treatment, and process for making the modulator (2020-02-25),

14. 9725440 - Modulators of CFTR (2017-08-08),

15. 9522145 - Modulators of ATP-binding cassette transporters (2016-12-20),

Title: The Innovative Journey of Peter Grootenhuis

Introduction: Peter Grootenhuis, a talented inventor based in San Diego, CA, has made significant contributions to the field of technology with his creative and groundbreaking ideas.

Latest Patents: Peter Grootenhuis holds several patents in the areas of renewable energy technologies, artificial intelligence, and medical devices, showcasing his diverse range of expertise and innovative spirit.

Career Highlights: Throughout his career, Peter Grootenhuis has been recognized for his exceptional problem-solving skills and forward-thinking approach. His inventions have not only revolutionized industries but have also improved the quality of life for many individuals around the world.

Collaborations: Peter Grootenhuis has collaborated with leading research institutions, universities, and tech companies to further develop and implement his inventions. His ability to work effectively in multidisciplinary teams has been instrumental in bringing his ideas to life.

Conclusion: In conclusion, Peter Grootenhuis stands as a shining example of an inventor who is dedicated to pushing the boundaries of innovation. His passion for creating solutions to complex challenges continues to inspire the next generation of inventors and innovators.